Gene-edited chickens to combat bird flu: Saviour or liability?
By Claire Robinson,
GMWatch
| 10. 19. 2023
Chicken farm by "L214 - éthique et animaux"
from Wiki Commons, licensed under CC by 3.0.
Scientists at the University of Edinburgh’s Roslin Institute — the animal research centre where Dolly the sheep was created — have used CRISPR gene editing to develop chickens that resist infection by bird flu, a disease that has decimated some wild bird populations and commercial poultry flocks across the world. But there are serious risks and limitations in the research, which were even indicated by the scientists involved but were largely ignored or downplayed by mainstream media outlets.
A press statement by the Roslin called the gene-edited chickens a “significant step in bird flu fight” and said, “Alterations to key gene associated with infection offer partial protection and suggest [a] path to flu-resistant poultry”. The findings are published in Nature Communications.
The Roslin reported that the scientists used gene-editing techniques to identify and change parts of chicken DNA that could limit the spread of avian flu in the birds. The bird flu virus needs a protein present in chicken cells, ANP32A, to...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...